STK33 Antikörper (AA 1-514)
(2 Referenzen)-
- Target Alle STK33 Antikörper anzeigen
- STK33 (serine/threonine Kinase 33 (STK33))
-
Bindungsspezifität
- AA 1-514
-
Reaktivität
- Human
-
Wirt
- Maus
-
Klonalität
- Monoklonal
-
Konjugat
- Dieser STK33 Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), ELISA, Immunoprecipitation (IP)
- Verwendungszweck
- Mouse monoclonal antibody raised against a full-length recombinant STK33.
- Sequenz
- MADSGLDKKS TKCPDCSSAS QKDVLCVCSS KTRVPPVLVV EMSQTSSIGS AESLISLERK KEKNINRDIT SRKDLPSRTS NVERKASQQQ WGRGNFTEGK VPHIRIENGA AIEEIYTFGR ILGKGSFGIV IEATDKETET KWAIKKVNKE KAGSSAVKLL EREVNILKSV KHEHIIHLEQ VFETPKKMYL VMELCEDGEL KEILDRKGHF SENETRWIIQ SLASAIAYLH NNDIVHRDLK LENIMVKSSL IDDNNEINLN IKVTDFGLAV KKQSRSEAML QATCGTPIYM APEVISAHDY SQQCDIWSIG VVMYMLLRGE PPFLASSEGK LFELIRKGEL HFENAVWNSI SDCAKSVLKQ LMKVDPAHRI TAKELLDNQW LTGNKLSSVR PTNVLEMMKE WKNNPESVEE NTTEEKNKPS TEEKLKSYQP WGNVPETNYT SDEEEEKQST TYEKQFPATS KDNFDMCSSS FTSSKLLPAE IKGEMEKTPV TPSQGTATKY PAKSGALSRT KKKL
- Kreuzreaktivität
- Human
- Produktmerkmale
- Antibody Reactive Against Recombinant Protein.
- Immunogen
- STK33 (AAH31231, 1 a.a. ~ 514 a.a) full-length recombinant protein with GST tag. MW of the GST tag alone is 26 KDa.
- Klon
- 4F7
- Isotyp
- IgG2a
- Top Product
- Discover our top product STK33 Primärantikörper
-
anti-serine/threonine Kinase 33 (STK33) (AA 1-514) antibody
STK33 Reaktivität: Human WB, ELISA, IF, IP Wirt: Maus Monoclonal 1F10 unconjugated
anti-serine/threonine Kinase 33 (STK33) (AA 1-514) antibodySTK33 Reaktivität: Human WB, ELISA, IF, IP, RNAi Wirt: Maus Monoclonal 6G1 unconjugated
anti-serine/threonine Kinase 33 (STK33) (AA 1-514) antibodySTK33 Reaktivität: Human WB, ELISA, IF, IP Wirt: Maus Monoclonal 4A12 unconjugated
anti-serine/threonine Kinase 33 (STK33) (AA 1-514) antibodySTK33 Reaktivität: Human WB, ELISA, IHC (p), IF Wirt: Maus Monoclonal 3F10 unconjugated
anti-serine/threonine Kinase 33 (STK33) (AA 231-514) antibodySTK33 Reaktivität: Human WB, ELISA, IHC, IF Wirt: Kaninchen Polyclonal unconjugated
anti-serine/threonine Kinase 33 (STK33) (N-Term) antibodySTK33 Reaktivität: Human WB, ELISA, IHC, IF, ICC Wirt: Kaninchen Polyclonal unconjugated
anti-serine/threonine Kinase 33 (STK33) (AA 1-515) antibodySTK33 Reaktivität: Human WB, ELISA, IHC, IHC (p), IF Wirt: Maus Monoclonal 3F10 unconjugated
anti-serine/threonine Kinase 33 (STK33) (N-Term) antibodySTK33 Reaktivität: Human WB, ELISA, IHC Wirt: Kaninchen Polyclonal unconjugated
anti-serine/threonine Kinase 33 (STK33) (AA 476-506), (C-Term) antibodySTK33 Reaktivität: Human WB, IHC (p) Wirt: Kaninchen Polyclonal RB2532 unconjugated
anti-serine/threonine Kinase 33 (STK33) (AA 1-514) antibodySTK33 Reaktivität: Human WB, IP Wirt: Kaninchen Polyclonal unconjugated
-
- Applikationshinweise
- Optimal working dilution should be determined by the investigator.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Buffer
- In 1x PBS, pH 7.4
- Handhabung
- Aliquot to avoid repeated freezing and thawing.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- Store at -20°C or lower. Aliquot to avoid repeated freezing and thawing.
-
-
: "Targeting of KRAS mutant tumors by HSP90 inhibitors involves degradation of STK33." in: The Journal of experimental medicine, Vol. 209, Issue 4, pp. 697-711, (2012) (PubMed).
: "Synthetic lethal interaction between oncogenic KRAS dependency and STK33 suppression in human cancer cells." in: Cell, Vol. 137, Issue 5, pp. 821-34, (2009) (PubMed).
-
: "Targeting of KRAS mutant tumors by HSP90 inhibitors involves degradation of STK33." in: The Journal of experimental medicine, Vol. 209, Issue 4, pp. 697-711, (2012) (PubMed).
-
- Target
- STK33 (serine/threonine Kinase 33 (STK33))
- Andere Bezeichnung
- STK33 (STK33 Produkte)
- Synonyme
- 4921505G21Rik antikoerper, AW061264 antikoerper, serine/threonine kinase 33 antikoerper, STK33 antikoerper, Stk33 antikoerper
- Hintergrund
-
Full Gene Name: serine/threonine kinase 33
Synonyms: - Gen-ID
- 65975
-
